profile_id,first_name,last_name,sub_title,profile_picture,background_image,profile_type,entity_urn,object_urn,birth_date,summary,location,premium,influencer,treasury_media,languages,industry,education,patents,awards,certifications,organizations,projects,publications,courses,test_scores,position_groups,volunteer_experiences,skills,network_info,related_profiles,contact_info
dr-m-mishra,Mudit,"Mishra, PhD",Scientist at Batavia Biosciences l Cell & Gene Therapy I Drug Development I Biomarkers | Assays | Quality & Compliance,https://media.licdn.com/dms/image/C4E03AQHfTpdUaWtTxg/profile-displayphoto-shrink_800_800/0/1624821179713?e=1697673600&v=beta&t=T2_OSzcOIxiHXOJ1Ybkcxehk6EV3uqf30pvn_deQis4,https://media.licdn.com/dms/image/C4D16AQEOlbLQmdZu3A/profile-displaybackgroundimage-shrink_350_1400/0/1559119389760?e=1697673600&v=beta&t=2hkorVrQNMTSaXQYFLXnwmSrzJxajl7ybiT1AUERt_c,personal,ACoAAAxFtyIBExIr6ylcdlojGVdAEi2MQf4K-rQ,205895458,,"★ Expert in Cell and Gene Therapy
★ Expert in running pre-clinical projects.
★ Expert in Assay Development
★ Medical writing: medical news, manuscripts, abstracts, summaries
★ ICH-GCP Certified-EFGCP and GxP compliance
★ Project Planning, Project Management, Risk Assessment, and Risk Mitigation.","{'country': None, 'short': 'Netherlands', 'city': None, 'state': None, 'default': 'Netherlands'}",False,False,[],"{'primary_locale': {'country': 'US', 'language': 'en'}, 'supported_locales': [{'country': 'US', 'language': 'en'}], 'profile_languages': [{'name': 'Dutch', 'proficiency': 'ELEMENTARY'}, {'name': 'English', 'proficiency': 'FULL_PROFESSIONAL'}, {'name': 'French', 'proficiency': 'ELEMENTARY'}, {'name': 'Hindi', 'proficiency': 'NATIVE_OR_BILINGUAL'}]}",Biotechnology,"[{'date': {'start': {'month': None, 'day': None, 'year': None}, 'end': {'month': None, 'day': None, 'year': None}}, 'school': {'name': 'KU Leuven', 'logo': 'https://media.licdn.com/dms/image/C560BAQHAtw6LesXG-w/company-logo_400_400/0/1519856403240?e=1700092800&v=beta&t=YGFv08j8qMzw3K6_6598PRsNnlK1l2muKk_hruAqB94', 'url': 'https://www.linkedin.com/school/ku_leuven/'}, 'degree_name': 'Doctor of Biomedical Sciences (PhD)', 'field_of_study': 'Biomedical Sciences, General'}, {'date': {'start': {'month': None, 'day': None, 'year': None}, 'end': {'month': None, 'day': None, 'year': None}}, 'school': {'name': 'Vellore Institute of Technology', 'logo': 'https://media.licdn.com/dms/image/C4D0BAQGgTYgPZiPkaA/company-logo_400_400/0/1519933404766?e=1700092800&v=beta&t=A-J6QFiWPu4x4DnYQkoJuGfhQDSsRtpUexACUK0nWKo', 'url': 'https://www.linkedin.com/school/vellore-institute-of-technology/'}, 'degree_name': ""Master's degree"", 'field_of_study': None}]","[{'inventors': [{'first_name': 'Mudit', 'last_name': 'Mishra, PhD', 'headline': 'Scientist at Batavia Biosciences l Cell & Gene Therapy I Drug Development I Biomarkers | Assays | Quality & Compliance', 'profile_picture': 'https://media.licdn.com/dms/image/C4E03AQHfTpdUaWtTxg/profile-displayphoto-shrink_800_800/0/1624821179713?e=1697673600&v=beta&t=T2_OSzcOIxiHXOJ1Ybkcxehk6EV3uqf30pvn_deQis4'}, {'first_name': 'Aastha', 'last_name': 'Jain', 'headline': 'Postdoctoral Associate at University of Massachusetts Medical School', 'profile_picture': None}, {'first_name': 'Archana', 'last_name': 'Chugh', 'headline': 'Professor, Indian Institute of Technology Delhi', 'profile_picture': 'https://media.licdn.com/dms/image/C5103AQFPr6gLj4jhLg/profile-displayphoto-shrink_800_800/0/1582609572627?e=1697673600&v=beta&t=kcFKFl_N4yG9bxI6b8f57JKD_q8IrjAyHiPzjjReNBg'}], 'patent_number': 'PCT/IN2017/050331', 'title': 'Agrobacterium derived cell penetrating peptides as nanocarriers ', 'issuer': 'in', 'date': {'month': 2, 'day': 22, 'year': 2022}, 'application_number': 'PCT/IN2017/050331'}]","[{'title': 'ESC travel grant award', 'description': 'ESC travel grant for attending Heart Failure (2019) & World Congress in Acute Heart Failure in Athens, Greece.', 'issuer': 'European Society of Cardiology', 'date': {'month': 5, 'day': None, 'year': 2019}}, {'title': 'Graduate Aptitude Test in Engineering-2014', 'description': None, 'issuer': 'National Coordination Board – GATE, Department of Higher Education, Ministry of Human Resources Development (MHRD), Government of India.', 'date': {'month': 3, 'day': None, 'year': 2014}}, {'title': 'Merit scholarship for best academic performance: VIT University 2013', 'description': None, 'issuer': 'VIT University, Vellore, India', 'date': {'month': 5, 'day': None, 'year': 2013}}, {'title': 'Awarded best paper in 4th International Conference on Science, Engineering and Technology (SET) 2012', 'description': None, 'issuer': 'School of Information Technology and Engineering, VIT University, India', 'date': {'month': None, 'day': None, 'year': 2012}}, {'title': 'First prize- Showcasing Entrepreneurship Ideas- VIT University', 'description': None, 'issuer': 'VIT University', 'date': {'month': None, 'day': None, 'year': 2012}}]","[{'name': 'ICH GOOD CLINICAL PRACTICE E6 (R2)', 'date': {'start': {'month': 7, 'day': None, 'year': 2021}, 'end': {'month': None, 'day': None, 'year': None}}, 'authority': 'The Global Health Network', 'url': None, 'license_number': 'f122e791-29ea-41c4-a120-22c033a78cd3', 'display_source': None, 'company': {'id': None, 'name': 'The Global Health Network', 'logo': 'https://media.licdn.com/dms/image/C560BAQFw4W49ymJ0SA/company-logo_400_400/0/1655916504569?e=1700092800&v=beta&t=k8AMk4HKaCu6T7ggEkTkAGthtLpzKHvl3rz33tHqHmI', 'url': None}}, {'name': 'Laboratory Animal Science (Article 9/FELASA)', 'date': {'start': {'month': 12, 'day': None, 'year': 2020}, 'end': {'month': None, 'day': None, 'year': None}}, 'authority': 'Utrecht University', 'url': None, 'license_number': None, 'display_source': None, 'company': {'id': None, 'name': 'Utrecht University', 'logo': 'https://media.licdn.com/dms/image/C510BAQG6HfmPTdJKXw/company-logo_400_400/0/1519884681258?e=1700092800&v=beta&t=QmNHoENF2Y_jlRACSsZ9TEtxi26_FphbWXhv1lZ3mrE', 'url': None}}, {'name': 'Project Management: Healthcare Projects', 'date': {'start': {'month': 11, 'day': None, 'year': 2018}, 'end': {'month': None, 'day': None, 'year': None}}, 'authority': 'LinkedIn', 'url': None, 'license_number': None, 'display_source': None, 'company': {'id': None, 'name': 'LinkedIn', 'logo': 'https://media.licdn.com/dms/image/C560BAQHaVYd13rRz3A/company-logo_400_400/0/1638831589865?e=1700092800&v=beta&t=F0wQ4YE76kB1XvMalNZgoXD44DF59ZvlIKaX7EZv3Pk', 'url': None}}, {'name': 'GCP Training Course For Experienced Researchers', 'date': {'start': {'month': 9, 'day': None, 'year': 2018}, 'end': {'month': None, 'day': None, 'year': None}}, 'authority': 'EFGCP -- European Forum for Good Clinical Practice', 'url': None, 'license_number': None, 'display_source': None, 'company': {'id': None, 'name': 'EFGCP - European Forum for Good Clinical Practice', 'logo': 'https://media.licdn.com/dms/image/C4E0BAQFQNtS9sy4boA/company-logo_400_400/0/1519880827017?e=1700092800&v=beta&t=4nmCx-9ModhRl3Q5-KnhVvdeCgUMHs1i3j8sT3u5HO8', 'url': None}}, {'name': 'Data Analytics in Health – From Basics to Business', 'date': {'start': {'month': 8, 'day': None, 'year': 2018}, 'end': {'month': None, 'day': None, 'year': None}}, 'authority': 'edX', 'url': 'https://courses.edx.org/courses/course-v1:KULeuvenX+DAHx+3T2016/course/', 'license_number': None, 'display_source': 'edx.org', 'company': {'id': None, 'name': 'edX', 'logo': 'https://media.licdn.com/dms/image/D4E0BAQFG13a41008Dg/company-logo_400_400/0/1688142646058?e=1700092800&v=beta&t=ECyNFVKn9TF5nYnFq0qmOPiuYIKkEUyo5Az5ql49WpU', 'url': None}}, {'name': 'Healthcare Finance, Economics and Risk', 'date': {'start': {'month': 8, 'day': None, 'year': 2018}, 'end': {'month': None, 'day': None, 'year': None}}, 'authority': 'edX', 'url': None, 'license_number': None, 'display_source': None, 'company': {'id': None, 'name': 'edX', 'logo': 'https://media.licdn.com/dms/image/D4E0BAQFG13a41008Dg/company-logo_400_400/0/1688142646058?e=1700092800&v=beta&t=ECyNFVKn9TF5nYnFq0qmOPiuYIKkEUyo5Az5ql49WpU', 'url': None}}, {'name': 'Introduction to Project Management', 'date': {'start': {'month': 7, 'day': None, 'year': 2018}, 'end': {'month': None, 'day': None, 'year': None}}, 'authority': 'edX', 'url': 'https://www.edx.org/course/introduction-project-management-adelaidex-project101x-1', 'license_number': None, 'display_source': 'edx.org', 'company': {'id': None, 'name': 'edX', 'logo': 'https://media.licdn.com/dms/image/D4E0BAQFG13a41008Dg/company-logo_400_400/0/1688142646058?e=1700092800&v=beta&t=ECyNFVKn9TF5nYnFq0qmOPiuYIKkEUyo5Az5ql49WpU', 'url': None}}, {'name': 'Research Integrity ', 'date': {'start': {'month': 3, 'day': None, 'year': 2017}, 'end': {'month': None, 'day': None, 'year': None}}, 'authority': 'KU Leuven', 'url': None, 'license_number': None, 'display_source': None, 'company': {'id': None, 'name': 'KU Leuven', 'logo': 'https://media.licdn.com/dms/image/C560BAQHAtw6LesXG-w/company-logo_400_400/0/1519856403240?e=1700092800&v=beta&t=YGFv08j8qMzw3K6_6598PRsNnlK1l2muKk_hruAqB94', 'url': None}}, {'name': 'Laboratory Animal Science (FELASA B)', 'date': {'start': {'month': 7, 'day': None, 'year': 2015}, 'end': {'month': None, 'day': None, 'year': None}}, 'authority': 'KU Leuven', 'url': None, 'license_number': None, 'display_source': None, 'company': {'id': None, 'name': 'KU Leuven', 'logo': 'https://media.licdn.com/dms/image/C560BAQHAtw6LesXG-w/company-logo_400_400/0/1519856403240?e=1700092800&v=beta&t=YGFv08j8qMzw3K6_6598PRsNnlK1l2muKk_hruAqB94', 'url': None}}, {'name': 'Biosafety', 'date': {'start': {'month': None, 'day': None, 'year': None}, 'end': {'month': None, 'day': None, 'year': None}}, 'authority': 'KU Leuven', 'url': None, 'license_number': None, 'display_source': None, 'company': {'id': None, 'name': 'KU Leuven', 'logo': 'https://media.licdn.com/dms/image/C560BAQHAtw6LesXG-w/company-logo_400_400/0/1519856403240?e=1700092800&v=beta&t=YGFv08j8qMzw3K6_6598PRsNnlK1l2muKk_hruAqB94', 'url': None}}]",[],"[{'title': 'Heart vector-mediated gene therapy: towards a clinically applicable cure for inherited cardiomyopathies', 'date': {'start': {'month': 12, 'day': None, 'year': 2021}, 'end': {'month': None, 'day': None, 'year': None}}, 'description': 'The only way to cure a genetic disease is to correct the disease-causing mutation. Thus, ongoing research is focused on developing gene therapies to correct these mutations. Building upon our recent advances in understanding the complex genetics behind cardiomyopathies and viral vector-mediated therapies, we aim to provide a) the first preclinical proof-of-concept (PoC) therapy for PLN R14del-induced cardiomyopathy and, in doing so, b) gather knowledge and assemble a technology toolbox permitting accelerating therapeutic development for inherited cardiomyopathies. To this end, we will perform head-to-head comparisons of different gene therapy technologies in (i) an in vitro model based on PLN R14del patient-derived iPSC-CMs, and (ii) humanized mouse and porcine models carrying the PLN R14del mutation', 'contributors': [{'type': 'standardizedContributor', 'first_name': 'Mudit', 'last_name': 'Mishra, PhD', 'name': None, 'headline': 'Scientist at Batavia Biosciences l Cell & Gene Therapy I Drug Development I Biomarkers | Assays | Quality & Compliance'}]}, {'title': 'Cardiovascular Moonshot RegMed XB: Regeneration of the human heart', 'date': {'start': {'month': 12, 'day': None, 'year': 2019}, 'end': {'month': None, 'day': None, 'year': None}}, 'description': 'The cardiovascular moonshot of RegMed XB is a comprehensive program based on the concept that we should be able to create a cardiac (re-)generative therapy that suits best the individual patient. One approach is to restore the heart function outside of the body (ex vivo). The advantage of this method is that we can solely treat the heart and assess cardiac function during treatment. During the time the heart is outside the body, the body will be connected to a heart-lung machine. After restoring the heart, it will be re-implanted. With this approach, gene therapy to cure hereditary diseases will also become possible. The researchers aim to stimulate the body’s own regenerative capacity including, for example, improving the contractility and perfusion of the heart muscle, repair, or replacement of coronary arteries and heart valves.', 'contributors': [{'type': 'standardizedContributor', 'first_name': 'Mudit', 'last_name': 'Mishra, PhD', 'name': None, 'headline': 'Scientist at Batavia Biosciences l Cell & Gene Therapy I Drug Development I Biomarkers | Assays | Quality & Compliance'}]}, {'title': 'Development of clinical prediction models for cardiac allograft vasculopathy and late graft failure in heart transplant recipients- A clinical Study ', 'date': {'start': {'month': 7, 'day': None, 'year': 2015}, 'end': {'month': None, 'day': None, 'year': None}}, 'description': 'Most of the survival improvement in heart transplant recipients in the past three decades is related to mortality reduction during the first post-transplant year. Mortality beyond 1 year after transplant has only slightly declined for patients transplanted in the past 20 years. After the first year, cardiac allograft vasculopathy (CAV) and late graft failure are the most important cause of death in heart transplant recipients. On one hand, this project is directed at the development of prediction models of CAV and late graft failure. On the other hand, the objective is to improve our understanding of the pathophysiology of late graft failure and its relation with epicardial CAV, microvascular CAV, and low-grade myocardial injury.', 'contributors': [{'type': 'standardizedContributor', 'first_name': 'Mudit', 'last_name': 'Mishra, PhD', 'name': None, 'headline': 'Scientist at Batavia Biosciences l Cell & Gene Therapy I Drug Development I Biomarkers | Assays | Quality & Compliance'}]}, {'title': 'High-density lipoprotein-targeted therapies for heart failure with preserved ejection fraction (HFpEF).', 'date': {'start': {'month': 6, 'day': None, 'year': 2015}, 'end': {'month': None, 'day': None, 'year': None}}, 'description': 'Heart failure is the cardiovascular epidemic of the 21st century.  This syndrome is a growing public health problem, the leading cause of hospitalization, and a major cause of mortality. Plasma high-density lipoprotein (HDL) cholesterol levels and levels of its major apolipoprotein (apo), apo A-I, are inversely correlated with the incidence of coronary heart disease. HDLs exert divergent functions that include actions mediated by HDL receptor ecto-F1-ATPase coupled to purinergic P2Y receptors, scavenger receptor class B, type I (SR-BI), and/or receptor activation by HDL cargo molecules. These pleiotropic properties offer perspectives for new therapeutic areas for HDL-targeted interventions. The general objective of this project is to study the effect of administration of apo A-I Milano/phospholipid complexes (HDL Milano) and hepatocyte-directed AAV8-mediated apo A-I gene transfer in murine models of HFpEF. ', 'contributors': [{'type': 'standardizedContributor', 'first_name': 'Mudit', 'last_name': 'Mishra, PhD', 'name': None, 'headline': 'Scientist at Batavia Biosciences l Cell & Gene Therapy I Drug Development I Biomarkers | Assays | Quality & Compliance'}]}, {'title': 'Mesenchymal Stem Cell Therapy in Myocardial Infarction, Stoke, Renal Failure and Diabetes', 'date': {'start': {'month': None, 'day': None, 'year': 2013}, 'end': {'month': None, 'day': None, 'year': 2013}}, 'description': None, 'contributors': [{'type': 'standardizedContributor', 'first_name': 'Mudit', 'last_name': 'Mishra, PhD', 'name': None, 'headline': 'Scientist at Batavia Biosciences l Cell & Gene Therapy I Drug Development I Biomarkers | Assays | Quality & Compliance'}]}, {'title': 'Cell penetrating peptides and Antimicrobial peptides, nanoparticle (CPP) mediated therapeutics.', 'date': {'start': {'month': 7, 'day': None, 'year': 2013}, 'end': {'month': 5, 'day': None, 'year': 2015}}, 'description': None, 'contributors': [{'type': 'standardizedContributor', 'first_name': 'Mudit', 'last_name': 'Mishra, PhD', 'name': None, 'headline': 'Scientist at Batavia Biosciences l Cell & Gene Therapy I Drug Development I Biomarkers | Assays | Quality & Compliance'}]}]","[{'name': 'Role of Oxidative Stress in Diabetic Cardiomyopathy', 'publisher': 'Antioxidants', 'url': 'https://doi.org/10.3390/antiox11040784', 'date': {'month': None, 'day': None, 'year': 2022}, 'authors': [{'type': 'standardizedContributor', 'first_name': 'Mudit', 'last_name': 'Mishra, PhD', 'name': None, 'headline': 'Scientist at Batavia Biosciences l Cell & Gene Therapy I Drug Development I Biomarkers | Assays | Quality & Compliance'}]}, {'name': 'Role of high-density lipoproteins in cardioprotection and in reverse remodeling: therapeutic implications', 'publisher': 'Elsevier: BBA - Molecular and Cell Biology of Lipids', 'url': 'https://doi.org/10.1016/j.bbalip.2021.159022', 'date': {'month': None, 'day': None, 'year': 2021}, 'authors': [{'type': 'standardizedContributor', 'first_name': 'Mudit', 'last_name': 'Mishra, PhD', 'name': None, 'headline': 'Scientist at Batavia Biosciences l Cell & Gene Therapy I Drug Development I Biomarkers | Assays | Quality & Compliance'}]}, {'name': 'Doxorubicin-induced cardiomyopathy: TERT gets to the heart of the matter', 'publisher': 'Molecular Therapy- Cell Press', 'url': 'https://doi.org/10.1016/j.ymthe.2021.03.001', 'date': {'month': None, 'day': None, 'year': 2021}, 'authors': [{'type': 'standardizedContributor', 'first_name': 'Mudit', 'last_name': 'Mishra, PhD', 'name': None, 'headline': 'Scientist at Batavia Biosciences l Cell & Gene Therapy I Drug Development I Biomarkers | Assays | Quality & Compliance'}]}, {'name': 'Damage-associated molecular patterns in myocardial infarction and heart transplantation; The road to translational success.', 'publisher': 'Frontiers in Immunology', 'url': 'https://doi.org/10.3389/fimmu.2020.599511', 'date': {'month': None, 'day': None, 'year': 2020}, 'authors': [{'type': 'standardizedContributor', 'first_name': 'Mudit', 'last_name': 'Mishra, PhD', 'name': None, 'headline': 'Scientist at Batavia Biosciences l Cell & Gene Therapy I Drug Development I Biomarkers | Assays | Quality & Compliance'}, {'type': 'standardizedContributor', 'first_name': 'Max', 'last_name': 'Silvis', 'name': None, 'headline': 'AIOS Cardiologie (Resident Cardiology)'}, {'type': 'standardizedContributor', 'first_name': 'Selma', 'last_name': 'Kaffka genaamd Dengler', 'name': None, 'headline': 'AIOS Cardiothoracic surgery and PhD Candidate'}, {'type': 'standardizedContributor', 'first_name': 'Niels', 'last_name': 'van der Kaaij', 'name': None, 'headline': 'Head of the Department of Cardiothoracic Surgery bij UMC Utrecht'}, {'type': 'standardizedContributor', 'first_name': 'Pieter', 'last_name': 'Doevendans', 'name': None, 'headline': 'Prof in Cardiology UMCU Utrecht The netherlands '}, {'type': 'standardizedContributor', 'first_name': 'Joost', 'last_name': 'Sluijter', 'name': None, 'headline': 'Professor Cellular and Translational Cardiology at UMC Utrecht'}, {'type': 'standardizedContributor', 'first_name': 'Saskia', 'last_name': 'de Jager', 'name': None, 'headline': 'Associate Professor at Universitair Medisch Centrum Utrecht'}]}, {'name': 'High-Density Lipoprotein-Targeted Therapies for Heart Failure', 'publisher': 'Biomedicines', 'url': 'https://doi.org/10.3390/biomedicines8120620', 'date': {'month': None, 'day': None, 'year': 2020}, 'authors': [{'type': 'standardizedContributor', 'first_name': 'Mudit', 'last_name': 'Mishra, PhD', 'name': None, 'headline': 'Scientist at Batavia Biosciences l Cell & Gene Therapy I Drug Development I Biomarkers | Assays | Quality & Compliance'}]}, {'name': 'The impact of air pollution and weather on cardiovascular events: The importance of time scale and historical air quality improvement', 'publisher': ' European Journal of Preventive Cardiology', 'url': 'https://doi.org/10.1177/2047487320938268', 'date': {'month': None, 'day': None, 'year': 2020}, 'authors': [{'type': 'standardizedContributor', 'first_name': 'Mudit', 'last_name': 'Mishra, PhD', 'name': None, 'headline': 'Scientist at Batavia Biosciences l Cell & Gene Therapy I Drug Development I Biomarkers | Assays | Quality & Compliance'}]}, {'name': 'Administration of apo A-I (Milano) nanoparticles reverses pathological remodelling, cardiac dysfunction, and heart failure in a murine model of HFpEF associated with hypertension', 'publisher': 'Scientific Reports-Nature Research', 'url': 'https://www.nature.com/articles/s41598-020-65255-y', 'date': {'month': None, 'day': None, 'year': 2020}, 'authors': [{'type': 'standardizedContributor', 'first_name': 'Mudit', 'last_name': 'Mishra, PhD', 'name': None, 'headline': 'Scientist at Batavia Biosciences l Cell & Gene Therapy I Drug Development I Biomarkers | Assays | Quality & Compliance'}, {'type': 'standardizedContributor', 'first_name': 'Ilayaraja', 'last_name': 'Muthuramu, Ph.D.', 'name': None, 'headline': 'Principal Scientist | Cell & Gene Therapy | Process & Analytical development  | Assay Development | Translational Research | Toxicology'}, {'type': 'standardizedContributor', 'first_name': 'Herman', 'last_name': 'Kempen', 'name': None, 'headline': 'Pharma Executive'}]}, {'name': 'Cholesterol lowering attenuates pressure overload‐induced heart failure in mice with mild hypercholesterolemia', 'publisher': 'Aging-SAGE Publications', 'url': 'https://www.ncbi.nlm.nih.gov/pubmed/31484164', 'date': {'month': None, 'day': None, 'year': 2019}, 'authors': [{'type': 'standardizedContributor', 'first_name': 'Mudit', 'last_name': 'Mishra, PhD', 'name': None, 'headline': 'Scientist at Batavia Biosciences l Cell & Gene Therapy I Drug Development I Biomarkers | Assays | Quality & Compliance'}, {'type': 'standardizedContributor', 'first_name': 'Ilayaraja', 'last_name': 'Muthuramu, Ph.D.', 'name': None, 'headline': 'Principal Scientist | Cell & Gene Therapy | Process & Analytical development  | Assay Development | Translational Research | Toxicology'}]}, {'name': 'Cholesterol-Lowering Gene Therapy Prevents Heart Failure with Preserved Ejection Fraction in Obese Type 2 Diabetic Mice', 'publisher': 'International Journal of Molecular Sciences-MDPI', 'url': 'https://www.mdpi.com/1422-0067/20/9/2222', 'date': {'month': None, 'day': None, 'year': 2019}, 'authors': [{'type': 'standardizedContributor', 'first_name': 'Mudit', 'last_name': 'Mishra, PhD', 'name': None, 'headline': 'Scientist at Batavia Biosciences l Cell & Gene Therapy I Drug Development I Biomarkers | Assays | Quality & Compliance'}, {'type': 'standardizedContributor', 'first_name': 'Ilayaraja', 'last_name': 'Muthuramu, Ph.D.', 'name': None, 'headline': 'Principal Scientist | Cell & Gene Therapy | Process & Analytical development  | Assay Development | Translational Research | Toxicology'}]}, {'name': 'Effective Treatment of Diabetic Cardiomyopathy and Heart Failure with Reconstituted HDL (Milano) in Mice', 'publisher': 'International Journal of Molecular Sciences-MDPI', 'url': 'https://www.mdpi.com/1422-0067/20/6/1273/htm', 'date': {'month': None, 'day': None, 'year': 2019}, 'authors': [{'type': 'standardizedContributor', 'first_name': 'Mudit', 'last_name': 'Mishra, PhD', 'name': None, 'headline': 'Scientist at Batavia Biosciences l Cell & Gene Therapy I Drug Development I Biomarkers | Assays | Quality & Compliance'}, {'type': 'standardizedContributor', 'first_name': 'Ilayaraja', 'last_name': 'Muthuramu, Ph.D.', 'name': None, 'headline': 'Principal Scientist | Cell & Gene Therapy | Process & Analytical development  | Assay Development | Translational Research | Toxicology'}, {'type': 'standardizedContributor', 'first_name': 'Herman', 'last_name': 'Kempen', 'name': None, 'headline': 'Pharma Executive'}]}, {'name': 'HDL dysfunction, function, and heart failure', 'publisher': 'Aging-SAGE Publications', 'url': 'https://doi.org/10.18632/aging.101775', 'date': {'month': None, 'day': None, 'year': 2019}, 'authors': [{'type': 'standardizedContributor', 'first_name': 'Mudit', 'last_name': 'Mishra, PhD', 'name': None, 'headline': 'Scientist at Batavia Biosciences l Cell & Gene Therapy I Drug Development I Biomarkers | Assays | Quality & Compliance'}, {'type': 'standardizedContributor', 'first_name': 'Ilayaraja', 'last_name': 'Muthuramu, Ph.D.', 'name': None, 'headline': 'Principal Scientist | Cell & Gene Therapy | Process & Analytical development  | Assay Development | Translational Research | Toxicology'}]}, {'name': 'Reconstituted HDL (Milano) Treatment Efficaciously Reverses Heart Failure with Preserved Ejection Fraction in Mice.', 'publisher': 'International Journal of Molecular Sciences-MDPI', 'url': 'https://www.mdpi.com/1422-0067/19/11/3399', 'date': {'month': None, 'day': None, 'year': 2018}, 'authors': [{'type': 'standardizedContributor', 'first_name': 'Mudit', 'last_name': 'Mishra, PhD', 'name': None, 'headline': 'Scientist at Batavia Biosciences l Cell & Gene Therapy I Drug Development I Biomarkers | Assays | Quality & Compliance'}, {'type': 'standardizedContributor', 'first_name': 'Ilayaraja', 'last_name': 'Muthuramu, Ph.D.', 'name': None, 'headline': 'Principal Scientist | Cell & Gene Therapy | Process & Analytical development  | Assay Development | Translational Research | Toxicology'}, {'type': 'standardizedContributor', 'first_name': 'Herman', 'last_name': 'Kempen', 'name': None, 'headline': 'Pharma Executive'}]}, {'name': 'Racial/ethnic differences in hypertension prevalence: Public health impact versus clinical importance of baseline data of the HELIUS study', 'publisher': 'European Journal of Preventive Cardiology-SAGE Journals', 'url': 'http://journals.sagepub.com/doi/abs/10.1177/2047487318809180?url_ver=Z39.88-2003&rfr_id=ori:rid:crossref.org&rfr_dat=cr_pub%3dpubmed', 'date': {'month': None, 'day': None, 'year': 2018}, 'authors': [{'type': 'standardizedContributor', 'first_name': 'Mudit', 'last_name': 'Mishra, PhD', 'name': None, 'headline': 'Scientist at Batavia Biosciences l Cell & Gene Therapy I Drug Development I Biomarkers | Assays | Quality & Compliance'}]}, {'name': 'Successful treatment of established heart failure in mice with recombinant HDL (Milano)', 'publisher': 'British Journal of Pharmacology- British Pharmacological Society Journals', 'url': 'https://bpspubs.onlinelibrary.wiley.com/doi/abs/10.1111/bph.14463', 'date': {'month': None, 'day': None, 'year': 2018}, 'authors': [{'type': 'standardizedContributor', 'first_name': 'Mudit', 'last_name': 'Mishra, PhD', 'name': None, 'headline': 'Scientist at Batavia Biosciences l Cell & Gene Therapy I Drug Development I Biomarkers | Assays | Quality & Compliance'}, {'type': 'standardizedContributor', 'first_name': 'Ilayaraja', 'last_name': 'Muthuramu, Ph.D.', 'name': None, 'headline': 'Principal Scientist | Cell & Gene Therapy | Process & Analytical development  | Assay Development | Translational Research | Toxicology'}, {'type': 'standardizedContributor', 'first_name': 'Md Ruhul', 'last_name': 'Amin, PhD', 'name': None, 'headline': 'Postdoctoral Researcher at Memorial University of Newfoundland'}, {'type': 'standardizedContributor', 'first_name': 'Herman', 'last_name': 'Kempen', 'name': None, 'headline': 'Pharma Executive'}]}, {'name': 'Hepatocyte-Specific SR-BI Gene Transfer Corrects Cardiac Dysfunction in Scarb1-Deficient Mice and Improves Pressure Overload-Induced Cardiomyopathy', 'publisher': 'Arteriosclerosis, Thrombosis, and Vascular Biology- American Heart Association', 'url': 'http://atvb.ahajournals.org/content/early/2018/07/03/ATVBAHA.118.310946', 'date': {'month': None, 'day': None, 'year': 2018}, 'authors': [{'type': 'standardizedContributor', 'first_name': 'Mudit', 'last_name': 'Mishra, PhD', 'name': None, 'headline': 'Scientist at Batavia Biosciences l Cell & Gene Therapy I Drug Development I Biomarkers | Assays | Quality & Compliance'}, {'type': 'standardizedContributor', 'first_name': 'Emma Louise', 'last_name': 'Robinson, PhD (Cantab)', 'name': None, 'headline': 'Postdoctoral Fellow at Anschutz Medical Campus, University of Colorado, United States. Lecturer at the University of Colorado Department of Integrative Biology. AHA BCVS Early career committee member'}, {'type': 'standardizedContributor', 'first_name': 'Ilayaraja', 'last_name': 'Muthuramu, Ph.D.', 'name': None, 'headline': 'Principal Scientist | Cell & Gene Therapy | Process & Analytical development  | Assay Development | Translational Research | Toxicology'}, {'type': 'standardizedContributor', 'first_name': 'Md Ruhul', 'last_name': 'Amin, PhD', 'name': None, 'headline': 'Postdoctoral Researcher at Memorial University of Newfoundland'}]}, {'name': 'Selective HDL-Raising Human Apo A-I Gene Therapy Counteracts Cardiac Hypertrophy, Reduces Myocardial Fibrosis, and Improves Cardiac Function in Mice with Chronic Pressure Overload', 'publisher': 'International Journal of Molecular Sciences- MDPI', 'url': 'https://www.ncbi.nlm.nih.gov/pubmed/28930153', 'date': {'month': None, 'day': None, 'year': 2017}, 'authors': [{'type': 'standardizedContributor', 'first_name': 'Mudit', 'last_name': 'Mishra, PhD', 'name': None, 'headline': 'Scientist at Batavia Biosciences l Cell & Gene Therapy I Drug Development I Biomarkers | Assays | Quality & Compliance'}, {'type': 'standardizedContributor', 'first_name': 'Ilayaraja', 'last_name': 'Muthuramu, Ph.D.', 'name': None, 'headline': 'Principal Scientist | Cell & Gene Therapy | Process & Analytical development  | Assay Development | Translational Research | Toxicology'}, {'type': 'standardizedContributor', 'first_name': 'Frank', 'last_name': 'Jacobs', 'name': None, 'headline': 'Principal Scientist at The Janssen Pharmaceutical Companies of Johnson & Johnson'}, {'type': 'standardizedContributor', 'first_name': 'Md Ruhul', 'last_name': 'Amin, PhD', 'name': None, 'headline': 'Postdoctoral Researcher at Memorial University of Newfoundland'}]}, {'name': 'Cholesterol-Lowering Gene Therapy Counteracts the Development of Non-ischemic Cardiomyopathy in Mice.', 'publisher': 'Molecular Therapy- Cell Press', 'url': 'https://www.ncbi.nlm.nih.gov/pubmed/28822689', 'date': {'month': None, 'day': None, 'year': 2017}, 'authors': [{'type': 'standardizedContributor', 'first_name': 'Mudit', 'last_name': 'Mishra, PhD', 'name': None, 'headline': 'Scientist at Batavia Biosciences l Cell & Gene Therapy I Drug Development I Biomarkers | Assays | Quality & Compliance'}, {'type': 'standardizedContributor', 'first_name': 'Ilayaraja', 'last_name': 'Muthuramu, Ph.D.', 'name': None, 'headline': 'Principal Scientist | Cell & Gene Therapy | Process & Analytical development  | Assay Development | Translational Research | Toxicology'}, {'type': 'standardizedContributor', 'first_name': 'Frank', 'last_name': 'Jacobs', 'name': None, 'headline': 'Principal Scientist at The Janssen Pharmaceutical Companies of Johnson & Johnson'}]}, {'name': 'Coconut Oil Aggravates Pressure Overload-Induced Cardiomyopathy without Inducing Obesity, Systemic Insulin Resistance, or Cardiac Steatosis', 'publisher': 'International Journal of Molecular Sciences- MDPI', 'url': 'http://www.mdpi.com/1422-0067/18/7/1565/', 'date': {'month': None, 'day': None, 'year': 2017}, 'authors': [{'type': 'standardizedContributor', 'first_name': 'Mudit', 'last_name': 'Mishra, PhD', 'name': None, 'headline': 'Scientist at Batavia Biosciences l Cell & Gene Therapy I Drug Development I Biomarkers | Assays | Quality & Compliance'}]}, {'name': 'Studies on heavy metal removal efﬁciency and antibacterial activity of chitosan prepared from shrimp shell waste', 'publisher': '3 Biotech- Springer', 'url': 'http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3964254/', 'date': {'month': None, 'day': None, 'year': 2013}, 'authors': [{'type': 'standardizedContributor', 'first_name': 'Mudit', 'last_name': 'Mishra, PhD', 'name': None, 'headline': 'Scientist at Batavia Biosciences l Cell & Gene Therapy I Drug Development I Biomarkers | Assays | Quality & Compliance'}, {'type': 'standardizedContributor', 'first_name': 'Dr. Selvarajan', 'last_name': 'E', 'name': None, 'headline': ' Assistant Professor at SRM University (Sri Ramaswamy Memorial University)'}, {'type': 'nonStandardizedContributor', 'first_name': None, 'last_name': None, 'name': 'suganthi vaithiyanathan', 'headline': None}, {'type': 'standardizedContributor', 'first_name': 'Jeny Singh', 'last_name': 'Paliwal', 'name': None, 'headline': 'Senior Research Associate at Premas Biotech'}, {'type': 'nonStandardizedContributor', 'first_name': None, 'last_name': None, 'name': 'Dr. Mohanasrinivasan V', 'headline': None}]}, {'name': 'Computational epitope prediction and docking studies of glycoprotein-G in Nipah virus', 'publisher': 'International Journal of Bioinformatics and Biological Science', 'url': 'http://www.indianjournals.com/ijor.aspx?target=ijor:ijbbs&volume=1&issue=1&article=006#aff002', 'date': {'month': None, 'day': None, 'year': 2013}, 'authors': [{'type': 'standardizedContributor', 'first_name': 'Mudit', 'last_name': 'Mishra, PhD', 'name': None, 'headline': 'Scientist at Batavia Biosciences l Cell & Gene Therapy I Drug Development I Biomarkers | Assays | Quality & Compliance'}, {'type': 'standardizedContributor', 'first_name': 'Dr. Pramod Kumar', 'last_name': 'Yadav', 'name': None, 'headline': 'Sr. Assistant Professor at Sam Higginbottom University of Agriculture,Technology and  Sciences, Allahabad'}]}]",[],[],"[{'company': {'id': 721980, 'name': 'Batavia Biosciences', 'logo': 'https://media.licdn.com/dms/image/C510BAQHpNvgw3724sA/company-logo_400_400/0/1519889562214?e=1700092800&v=beta&t=b__HF1O0I_8xw_lcqughUXHGpX1DJjPAMuiLP44Vbx8', 'url': 'https://www.linkedin.com/company/batavia-biosciences/', 'employees': {'start': 51, 'end': 200}}, 'date': {'start': {'month': 8, 'day': None, 'year': 2023}, 'end': {'month': None, 'day': None, 'year': None}}, 'profile_positions': [{'location': None, 'date': {'start': {'month': 8, 'day': None, 'year': 2023}, 'end': {'month': None, 'day': None, 'year': None}}, 'company': 'Batavia Biosciences', 'description': None, 'title': 'Scientist', 'employment_type': 'Full-time'}]}, {'company': {'id': 1362689, 'name': 'MeiraGTx Netherlands B.V.', 'logo': 'https://media.licdn.com/dms/image/C560BAQF0ai33Xl6BUg/company-logo_400_400/0/1595408639006?e=1700092800&v=beta&t=2stIHw4iqnzGmv9ZL5RRaRgCLL7PP4cH3Wu9hBqUYmE', 'url': 'https://www.linkedin.com/company/meiragtx-bv/', 'employees': {'start': 11, 'end': 50}}, 'date': {'start': {'month': 11, 'day': None, 'year': 2022}, 'end': {'month': 8, 'day': None, 'year': 2023}}, 'profile_positions': [{'location': 'Amsterdam Area', 'date': {'start': {'month': 11, 'day': None, 'year': 2022}, 'end': {'month': 8, 'day': None, 'year': 2023}}, 'company': 'MeiraGTx Netherlands B.V.', 'description': '• Pre-clinical development of gene therapies.\n• Responsible for the in-house and outsourced non-clinical activities with project-specific methods (GxP). \n• Generation of (qualified & on-time) pre-clinical data to support future clinical development of leads and products. \n• Ensures that external contractors adhere to predefined quality standards and timelines. \n• Coordinating with internal manufacturing departments in order to deliver the qualified study materials on time.\n• Provide scientific and operational input to project teams to achieve the expectations\n• Setting up relevant hiPSC / mouse models/ Porcine models for disease modeling', 'title': 'Scientist, Non-Clinical Development', 'employment_type': 'Full-time'}]}, {'company': {'id': 18213607, 'name': 'RegMed XB', 'logo': 'https://media.licdn.com/dms/image/D4E0BAQGNrLygbcXikg/company-logo_400_400/0/1688378088156?e=1700092800&v=beta&t=LXGPp4MU17vDE1AgRTp9l_WkMLMFBAUxNt7YhqcJfdA', 'url': 'https://www.linkedin.com/company/regmed-xb/', 'employees': {'start': 201, 'end': 500}}, 'date': {'start': {'month': 8, 'day': None, 'year': 2019}, 'end': {'month': 11, 'day': None, 'year': 2022}}, 'profile_positions': [{'location': 'The Randstad, Netherlands', 'date': {'start': {'month': 8, 'day': None, 'year': 2019}, 'end': {'month': 11, 'day': None, 'year': 2022}}, 'company': 'RegMed XB', 'description': '• Design, planning, and budgeting of multiple in-vitro and in-vivo studies for the screening and development of biologics against range of diseases\n• Setup and maintenance of the research plan\n• Provide scientific input for target selection and efficacy testing\n• Writing and reviewing R&D reports, SOPs, and work instructions\n• Subject matter expert for gene therapy and animal research\n• Design and management of all in-house animal experimentation\n• Writing of license for the Central Authority for Scientific Procedures on Animals (CCD) and \n work protocols for animal experimentation procedures\n• Article 9 responsible for in-house in vivo experiments and GMO regulations', 'title': 'Research Scientist', 'employment_type': 'Full-time'}]}, {'company': {'id': 8517, 'name': 'UMC Utrecht', 'logo': 'https://media.licdn.com/dms/image/C4E0BAQG50uAl6TiV2g/company-logo_400_400/0/1638562574508?e=1700092800&v=beta&t=mTnteZlB6Kim5wFZ0jF1f833Vs7TDAOEL2ioXOZvP-0', 'url': 'https://www.linkedin.com/company/umcutrecht/', 'employees': {'start': 10001, 'end': None}}, 'date': {'start': {'month': 8, 'day': None, 'year': 2019}, 'end': {'month': 10, 'day': None, 'year': 2022}}, 'profile_positions': [{'location': 'Utrecht Area, Netherlands', 'date': {'start': {'month': 8, 'day': None, 'year': 2019}, 'end': {'month': 10, 'day': None, 'year': 2022}}, 'company': 'UMC Utrecht', 'description': 'Research and Development. Innovating. Supervising. Troubleshooting. Scientific Writing and Communication.', 'title': 'Research Scientist', 'employment_type': 'Full-time'}]}, {'company': {'id': 3629, 'name': 'KU Leuven', 'logo': 'https://media.licdn.com/dms/image/C560BAQHAtw6LesXG-w/company-logo_400_400/0/1519856403240?e=1700092800&v=beta&t=YGFv08j8qMzw3K6_6598PRsNnlK1l2muKk_hruAqB94', 'url': 'https://www.linkedin.com/school/ku_leuven/', 'employees': {'start': 10001, 'end': None}}, 'date': {'start': {'month': 7, 'day': None, 'year': 2015}, 'end': {'month': 7, 'day': None, 'year': 2019}}, 'profile_positions': [{'location': 'Leuven, Flemish Region, Belgium', 'date': {'start': {'month': 7, 'day': None, 'year': 2015}, 'end': {'month': 7, 'day': None, 'year': 2019}}, 'company': 'KU Leuven', 'description': '• Developed novel murine models of heart failure, diabetes, and metabolic disease\n• Executed pre-clinical and clinical projects with successful HDL-targeted therapies\n• Established invasive pressure-volume loop (gold standard) for cardiac function analysis in murine models\n• Showed therapeutic efficacy of recombinant protein and AAV-gene therapy in various animal models of heart failure and metabolic disease.\n• Developed a clinical prediction model for heart transplant recipients\n• Represented our research group in many international meetings and published more than 15 high-impact research articles', 'title': 'Doctor of  Biomedical Sciences (PhD)', 'employment_type': 'Full-time'}]}, {'company': {'id': 157264, 'name': 'Indian Institute of Technology, Delhi', 'logo': 'https://media.licdn.com/dms/image/C4E0BAQEtUTK1TcRY4w/company-logo_400_400/0/1574847417400?e=1700092800&v=beta&t=fh2QC3_VPFf--sxhvA-o47kaMjmeNgMYjSqKVU1oj7c', 'url': 'https://www.linkedin.com/school/iitdelhi/', 'employees': {'start': 1001, 'end': 5000}}, 'date': {'start': {'month': 9, 'day': None, 'year': 2013}, 'end': {'month': 5, 'day': None, 'year': 2015}}, 'profile_positions': [{'location': 'New Delhi Area, India', 'date': {'start': {'month': 9, 'day': None, 'year': 2013}, 'end': {'month': 5, 'day': None, 'year': 2015}}, 'company': 'Indian Institute of Technology, Delhi', 'description': '• Investigated peptide-mediated therapeutics in cancer and infectious diseases. \n• Screened novel cell-penetrating and antimicrobial peptide drugs using high-throughput screening assays.\n• Planned and executed assays for dose-dependent and the cytotoxic response of peptide drugs.\n• Confocal microscopy, qPCR, cell culture,  and Facs analysis (FACS)\n• Wrote scientific papers and technical documents (deviations, procedures, protocols, reports), involving evaluation and implementation of the standard operating procedure.\n• Research led to the filing of an American Patent: Agrobacterium derived cell-penetrating peptides as Nano-carriers (PCT/IN2017/050331).', 'title': 'Researcher', 'employment_type': 'Full-time'}]}, {'company': {'id': 164340, 'name': 'Indian Institute of Science (IISc)', 'logo': 'https://media.licdn.com/dms/image/C560BAQHlKBtJ82x7_Q/company-logo_400_400/0/1590126941204?e=1700092800&v=beta&t=dqWD7P5CEqJyLCtp-9UU-fCA62eiP3YIwcC0HEvycA4', 'url': 'https://www.linkedin.com/school/indian-institute-of-science/', 'employees': {'start': 1001, 'end': 5000}}, 'date': {'start': {'month': 1, 'day': None, 'year': 2013}, 'end': {'month': 6, 'day': None, 'year': 2013}}, 'profile_positions': [{'location': 'Bangalore', 'date': {'start': {'month': 1, 'day': None, 'year': 2013}, 'end': {'month': 6, 'day': None, 'year': 2013}}, 'company': 'Indian Institute of Science (IISc)', 'description': 'Project: Cloning and expression of tyrosinase in Melan-ink cells and studying protein-protein interaction using yeast two-hybrid system.\n-Gene cloning, PCR amplification, Vector engineering to enhance protein expression in mammalian cells\n-Immunoprecipitation pull-down assay Confocal Microscopy, Cell-based assays\n-Yeast two-hybrid system to study protein-protein interaction.', 'title': 'Master Thesis', 'employment_type': 'Internship'}]}, {'company': {'id': 27302501, 'name': 'DR. MOREPEN LIMITED', 'logo': 'https://media.licdn.com/dms/image/C4E0BAQFj9xmjoi9Ccg/company-logo_400_400/0/1624266985741?e=1700092800&v=beta&t=FqP1mMFRUuLEHX8Jr1snrfOCxyb3zZ-Y5TXUSa-Zuko', 'url': 'https://www.linkedin.com/company/dr.-morepen-limited/', 'employees': {'start': 201, 'end': 500}}, 'date': {'start': {'month': 6, 'day': None, 'year': 2010}, 'end': {'month': 7, 'day': None, 'year': 2010}}, 'profile_positions': [{'location': 'Solan, Himachal Pradesh, India', 'date': {'start': {'month': 6, 'day': None, 'year': 2010}, 'end': {'month': 7, 'day': None, 'year': 2010}}, 'company': 'DR. MOREPEN LIMITED', 'description': '• Preparation and documentation of detailed test plans, test cases, and defect reports in accordance with global drug regulations.\n• Carried out testing of raw materials (API) and finished products.\n• Helped in preparation and review of technical documents including batch manufacturing records, interoffice memos, SOP, IOP & EOP, SAM, process protocol, and analytical notebook.\n• Microbial testing of finished products (drugs) for QA, QC, and GMP compliance.', 'title': 'Industrial Trainee- Quality Control/ Quality Assurance', 'employment_type': 'Internship'}]}]","[{'date': {'start': {'month': 4, 'day': None, 'year': 2015}, 'end': {'month': None, 'day': None, 'year': None}}, 'role': 'Department Coordinator (Student)- Open House IIT D', 'company': {'id': None, 'name': 'Indian Institute of Technology, Delhi', 'logo': 'https://media.licdn.com/dms/image/C4E0BAQEtUTK1TcRY4w/company-logo_400_400/0/1574847417400?e=1700092800&v=beta&t=fh2QC3_VPFf--sxhvA-o47kaMjmeNgMYjSqKVU1oj7c', 'url': 'https://www.linkedin.com/school/iitdelhi/'}, 'cause': 'SCIENCE_AND_TECHNOLOGY', 'description': None}, {'date': {'start': {'month': 9, 'day': None, 'year': 2015}, 'end': {'month': 7, 'day': None, 'year': 2019}}, 'role': 'Core Committee Member', 'company': {'id': None, 'name': 'Indian Student Association Leuven (ISAL)', 'logo': None, 'url': None}, 'cause': 'ARTS_AND_CULTURE', 'description': 'Mudit, along with the other ISAL team members, organized multiple cultural events and helped incoming students to get familiarize with Belgium.\n\nMore details about ISAL can be found here: http://www.isal.be/'}, {'date': {'start': {'month': 7, 'day': None, 'year': 2014}, 'end': {'month': 5, 'day': None, 'year': 2015}}, 'role': 'Teaching Assistant', 'company': {'id': None, 'name': 'Indian Institute of Technology, Delhi', 'logo': 'https://media.licdn.com/dms/image/C4E0BAQEtUTK1TcRY4w/company-logo_400_400/0/1574847417400?e=1700092800&v=beta&t=fh2QC3_VPFf--sxhvA-o47kaMjmeNgMYjSqKVU1oj7c', 'url': 'https://www.linkedin.com/school/iitdelhi/'}, 'cause': 'EDUCATION', 'description': '\n'}, {'date': {'start': {'month': None, 'day': None, 'year': 2012}, 'end': {'month': None, 'day': None, 'year': None}}, 'role': 'Student Volunteer - Open day IISc', 'company': {'id': None, 'name': 'Indian Institute of Science (IISc)', 'logo': 'https://media.licdn.com/dms/image/C560BAQHlKBtJ82x7_Q/company-logo_400_400/0/1590126941204?e=1700092800&v=beta&t=dqWD7P5CEqJyLCtp-9UU-fCA62eiP3YIwcC0HEvycA4', 'url': 'https://www.linkedin.com/school/indian-institute-of-science/'}, 'cause': 'EDUCATION', 'description': None}]","['Good Manufacturing Practice (GMP)', 'Product Development', 'In Vitro', 'Western Blotting', 'Pre-clinical Studies', 'Gene Therapy', 'Cell Culture', 'In Vivo', 'qRT-PCR', 'CRO Management', 'Molecular Biology', 'Microbiology', 'Clinical Research', 'Genomics', 'Biochemistry', 'PCR', 'Life Sciences', 'Biotechnology', 'ELISA', 'Cell Biology']",,,
